Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors

BMC Gastroenterology

Volumn 8, Issue , 2008, Pages

  Gerson, Lauren B ^a   Triadafilopoulos, George ^a   Sahbaie, Peyman ^b   Young, Winston ^c   Sloan, Sheldon ^d   Robinson, Malcolm ^e   Miner Jr , Philip B ^e   Gardner, Jerry D ^f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c Blossomtech Inc   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f Science for Organizations Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;

ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; PH MEASUREMENT; POSTPRANDIAL STATE; PREDICTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; STOMACH PH; STOMACH SECRETION; TIME SERIES ANALYSIS; TREATMENT DURATION; TREND STUDY; CIRCADIAN RHYTHM; ESOPHAGEAL PH MONITORING; ESOPHAGUS; PATHOPHYSIOLOGY; PH; PHYSIOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; CIRCADIAN RHYTHM; ESOPHAGEAL PH MONITORING; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; OMEPRAZOLE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES;

EID: 44949219237     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-8-15     Document Type: Article

References (32)

1. Milkes D Gerson LB Triadafilopoulos G Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD) Am J Gastroenterol 2004, 99:991-996. 10.1111/j.1572-0241.2004.30124.x 15180715
2. Achem SR Acid inhibition in GERD - How much is enough? Am J Gastroenterol 2004, 99:997-999. 10.1111/j.1572-0241.2004.40316.x 15180716
3. Gardner JD Perdomo C Sloan S Hahne WF Barth JA Rodriguez-Stanley S Robinson M Integrated acidity and rabeprazole pharmacology Aliment Pharmacol Ther 2002, 16:455-464. 10.1046/j.1365-2036.2002.01158.x 11876698
4. Gardner JD Sloan S Miner PB Jr Robinson M Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease Aliment Pharmacol Ther 2003, 17:945-953. 10.1046/ j.1365-2036.2003.01533.x 12656697
5. Gardner JD Young W Sloan S Robinson M Miner PB Jr The effects of changing temperature correction factors on measures of acidity calculated from gastric and esophageal pH recordings Aliment Pharmacol Ther 2006, 23:629-638. 10.1111/j.1365-2036.2006.02787.x 16480402
6. Pandolfino JE Schriener MA Lee TJ Zhang Q Boniquit C Kahrilas PJ Comparison of the Bravo™ Wireless and Digitrapper™ Cathete-Based monitoring systems for measuring esophageal acid exposure Am J Gastroenterol 2005, 100:1466-1476. 10.1111/j.1572-0241.2005.41719.x 15984967
7. Gardner JD Sloan S Miner PB Jr Robinson M Determination of the reduction in gastric acidity necessary to prevent pathologic esophageal reflux in GERD patients treated with a proton pump inhibitor Aliment Pharmacol Ther 2003, 17:955-964. 10.1046/j.1365-2036.2003.01532.x 12656698
8. Berry DA Statistics: A Bayesian Perspective Duxbury Press, Belmont; 1996.
9. Schindlbeck NE Heinrich C Konig A Dendorfer A Pace F Muller-Lissner SA Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease Gastroenterology 1987, 93:85-90. 3582918
10. Weiner GJ Morgan TM Copper JB Wu WC Castell DO Sinclair JW Richter JE Ambulatory 24-hour esophageal pH monitoring Dig Dis Sci 1988, 33:1127-1133. 10.1007/BF01535789 3044715
11. Masclee AAM De Best ACAM De Graaf R Cluysenaer OJJ Jansen JBMJ Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease Scand J Gastroenterol 1990, 25:225-230. 2181620
12. Schindlbeck NE Ippisch H Klausner AG Muller-Lissner SA Which pH threshold is best in esophageal pH monitoring? Am J Gastroenterol 1991, 86:1138-1141. 1882791
13. Jamieson JR Stein HJ DeMeester TR Bonavina L Schwizer W Hinder RA Albertucci Ambulatory 24-H esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility Am J Gastroenterol 1992, 87:1102-1111. 1519566
14. Ghillebert G Demeyere AM Janssens J Vantrappen G How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci 1995, 40:1317-1324. 10.1007/ BF02065545 7781454
15. Swets JA Measuring the accuracy of diagnostic systems Science 1988, 240:1285-1293. 10.1126/science.3287615 3287615
16. McNeil BJ Keeler E Adelstein SJ Primer on certain elements of medical decision making New Eng J Med 1975, 293:211-215. 806804
17. Hanley JA McNeil BJ A method of comparing the areas under a receiver operating characteristic (ROC) curve Radiology 1982, 143:29-36. 7063747
18. Hanley JA McNeil BJ The meaning and use of the area under receiver operating characteristic curves derived from the same cases Radiology 1983, 148:839-843. 6878708
19. Peghini PL Katz PO Castell DO Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects Gastroenterology 1998, 115:1335-1339. 10.1016/S0016-5085(98)70010-1 9834259
20. Peghini PL Katz PO Bracy NA Castell DO Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors Am J Gastroenterol 1998, 93:763-767. 10.1111/j.1572-0241.1998.221_a.x 9625124
21. Katz PO Anderson C Khoury R Castell DO Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors Aliment Pharmacol Ther 1998, 12:1231-1234. 10.1046/ j.1365-2036.1998.00419.x 9882031
22. Hatlebakk JG Katz PO Kuo B Castell DO Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily Aliment Pharmacol Ther 1998, 11:1235-1240. 10.1046/j.1365-2036.1998.00426.x
23. Khoury RM Katz PO Hammod R Castell DO Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH Aliment Pharmacol Ther 1999, 13:675-678. 10.1046/ j.1365-2036.1999.00499.x 10233192
24. Ours TM Fackler WK Richter JE Vaezi MF Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure Am J Gastroenterol 2003, 98:545-550. 10.1111/j.1572-0241.2003.07304.x 12650785
25. Castell D Bagin R Goldlust B Major J Hepburn B Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease Aliment Pharmacol Ther 2005, 21:1467-1474. 10.1111/j.1365-2036.2005.02513.x 15948814
26. Zerbib F Roman S Ropert A Bruley des Varannes S Poudeoux P Chaput U Mion F Verin E Galmiche J-P Sifrim D Esophageal pH-impedance monitoring and symptom analysis in GERD: A study in patients off and on therapy Am J Gastroenterol 2006, 101:1956-1963. 10.1111/j.1572-0241.2006.00711.x 16848801
27. Sontag SJ Rolling review: Gastro-oesophageal reflux disease Aliment Pharmacol Ther 1993, 7:293-312. 8364135
28. Katzka DA Castell DO Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in Barrett's esophagus Am J Gastroenterol 1994, 89:989-991. 8017396
29. Ouatu-Lascar R Triadafilopoulos G Complete elimination of reflux symptoms does not guarantee normalization of intra-esophageal acid reflux in patients with Barrett's esophagus Am J Gastroenterol 1998, 93:711-716. 10.1111/j.1572-0241.1998.211_a.x 9625114
30. Fass R Sampliner RE Malagon IB Hayden CW Camargo L Wendel CS Garewal HS Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor Aliment Pharmacol Ther 2000, 14:597-602. 10.1046/j.1365-2036.2000.00749.x 10792123
31. Arnestad JS Kleveland PM Waldum HL In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity Aliment Pharmacol Ther 1997, 11:355-358. 10.1046/ j.1365-2036.1997.300000.x 9146775
32. Hedenstrom H Alm C Kraft M Grahnen A Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers Aliment Pharmacol Ther 1997, 11:1137-1141. 10.1046/ j.1365-2036.1997.00264.x 9663842